Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07114289
Recruiting Not applicable

Spontaneous Breathing Trials Using Pressure Support or T-Piece in Overweight and Obese Patients

NCT07114289 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-09-29
Last updated
2025-11-17

Condition(s) studied

Mechanical VentilationExtubationObesity &Amp; OverweightRespiratory Failure

Investigational drug(s) / intervention(s)

Spontaneous breathing trial using pressure support ventilationSpontaneous breathing trial using T-Piece

Spontaneous breathing trial using pressure support ventilation: Patients will receive low level pressure support ventilation for 1 hour before extubation

Spontaneous breathing trial using T-Piece: Patients will receive a T-piece with oxygen for 1 hour before extubation

Study summary

This study aims to find out which method of spontaneous breathing trial (SBT) better helps overweight and obese ICU patients prepare for extubation, which is the removal of the breathing tube. The two methods being compared are pressure support ventilation (PSV) and the T-piece.

Participants are adults with a body mass index (BMI) of 25 or higher who have been on a breathing machine (invasive mechanical ventilation) for more than 24 hours. Before removing the breathing tube, participants will be randomly assigned to receive either a PSV or a T-piece trial for 1 hour. After that, doctors will decide if they are ready for extubation.

The main question this study wants to answer is: Which method leads to a higher rate of successful extubation-defined as not needing to be reintubated within 72 hours?

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1\. Patients had undergone intubation and mechanical ventilation for more than 24 hours prior to the first spontaneous breathing trial. 2\. Adult patients aged ≥ 18 years. 3. BMI ≥ 25 kg/m². 4. Meeting all the Inter national Consensus Conference on weaning criteria: 1. Stable vital signs: heart rate \< 140 beats/min, systolic blood pressure: 90-160 mmHg, and no use of vasopressors or use of minimal doses (\<0.2 µg/kg per min). 2. Respiratory rate ≤ 35 breaths/min. 3. Adequate oxygenation, defined as either SpO2 \> 90% with FiO2 ≤ 0.4, or PaO2/FiO2 \> 150 mmHg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O. 4. Adequate cough strength (MIP \< -20 cmH2O). 5. An awake state, defined as a score of Richmond Agitation-Sedation Scale between +1 and -2, or Glasgow Coma Scale \> 8. 6. No continuous sedation. 5. Informed consent provided by the patient or their relatives. Exclusion Criteria: 1. Patients with tracheostomy. 2. Patients who had been admitted for traumatic brain injury. 3. Patients who had preexisting peripheral neuromuscular disease (underlying myopathy or myasthenia gravis). 4. Patients who had a do-not-reintubate order at the time of the initial spontaneous breathing trial were excluded 5. Patients who have already undergone a first spontaneous breathing trial. 6. Patients who had undergone extubation without an SBT 7. Protected populations: pregnant or breastfeeding women, individuals under guardianship, or those under legal protection. 8. Patients who refused to participate during the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Taipei Medical University Hospital Taipei Taiwan Recruiting

More Taipei Medical University Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07114289 on ClinicalTrials.gov ↗ ← All trials in Taiwan